September 11, 2025 09:00 ET | Source: Nacuity Pharmaceuticals, Inc. NPI-001 shows more than 50% reduction in photoreceptor loss caused…
Detroit, Aug. 23, 2025 (GLOBE NEWSWIRE) -- This press release is for informational purposes only. The content provided does not…
New York, Aug. 23, 2025 (GLOBE NEWSWIRE) -- This press release is for informational purposes only. The content provided does…
The Company's scientific team describes how they successfully disguised cancer cells and tricked immune cells into attacking them and reveals…
Clinical adoption of Curodont™ is helping to elevate the standard of care in caries management Leading clinical experts herald Curodont™…
AUSTIN, Texas, July 21, 2025 /PRNewswire/ -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center…
July 11, 2025 16:30 ET | Source: Ultragenyx Pharmaceutical Inc. Complete Response Letter (CRL) cited specific chemistry, manufacturing and controls…
Expanded indication makes SIR-Spheres® the first and only radioembolization therapy in the U.S. approved to treat both unresectable hepatocellular carcinoma…
June 06, 2025 16:01 ET | Source: Keros Therapeutics, Inc. LEXINGTON, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics,…
Two pioneering scientists received The Brain Prize 2025 for their discoveries that open an entirely new way of thinking about…